Med ePad, a Liverpool, England-based company specializing in mobile Healthcare, has received financing from the North West Fund for Digital and Creative for 150,000 pounds ($236,800 U.S.).
The money will fund the ongoing trials with patients in the country’s National Health Service.
Med Epad has already created three medical applications. The first is an informational app for patients with prostate cancer, which allows them to manage their self-care. It provides information about the disease and treatment options. Patients can also schedule appointments with their doctors, as well as record their progress struggling with the cancer. Med ePad provides the actual tablet the app runs on.
Med eVision delivers healthcare information right to patients’ TV screens. It integrates with other data sources, including electronic health records and healthcare plan. Med eVision also allows for sharing of important information, as well as allowing patients to get more involved with their own care. The interface is accessed through a remote control.
The company has also developed a maternity app, which offers a pregnancy tracker, prenatal care information, connections to patient forums, an option for the patient to record daily activity, birthing plans and postnatal care, including feeding and baby growth.
Although we're still at the early stages of developing their communications strategies, we are already seeing their growth potential as they start to disrupt existing marketplaces,” Anna Heyes, managing director of Active Profile, another Liverpool-based company collaborating with Med ePad, said in 2011. "Our science and technology portfolio is continuing to grow and is supported by a strong pipeline of future work in this field.
A report by Mobile Health Market said that spending on mobile healthcare dropped in the last quarter of fiscal 2012 from $200.7 million invested. A total of $907.7 million was spent on mobile healthcare technology in 2012.
Edited by Rich Steeves